Immatics NV (IMTX)
11.02
-0.26
(-2.30%)
USD |
NASDAQ |
May 31, 16:00
11.02
0.00 (0.00%)
After-Hours: 20:00
Immatics Cash from Investing (Quarterly): -262.66M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -262.66M |
| December 31, 2023 | 65.23M |
| September 30, 2023 | -76.80M |
| June 30, 2023 | -18.42M |
| March 31, 2023 | -3.994M |
| December 31, 2022 | -100.77M |
| September 30, 2022 | -68.78M |
| June 30, 2022 | -58.24M |
| March 31, 2022 | 6.549M |
| Date | Value |
|---|---|
| December 31, 2021 | -2.124M |
| September 30, 2021 | 23.41M |
| June 30, 2021 | -15.50M |
| March 31, 2021 | 3.084M |
| December 31, 2020 | -0.0288M |
| September 30, 2020 | -30.82M |
| June 30, 2020 | 33.85M |
| March 31, 2020 | -21.21M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-262.66M
Minimum
Mar 2024
65.23M
Maximum
Dec 2023
-31.01M
Average
-15.50M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| MorphoSys AG | -- |
| Affimed NV | 1.755M |
| InflaRx NV | 29.27M |
| BioNTech SE | -2.503B |
| CureVac NV | -5.527M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.42M |
| Cash from Financing (Quarterly) | 189.70M |
| Free Cash Flow | -29.05M |
| Free Cash Flow Per Share (Quarterly) | -0.4284 |
| Free Cash Flow to Equity (Quarterly) | -45.38M |
| Free Cash Flow to Firm (Quarterly) | -45.38M |
| Free Cash Flow Yield | -3.00% |